evidence boundary
unknownexperimental
An evidence atom is an inspectable support unit. It is not a finding by itself; it supports or challenges a finding through review.
frontiers / frontier
Evidence atom
back to sourcesevidence boundary
unknownAn evidence atom is an inspectable support unit. It is not a finding by itself; it supports or challenges a finding through review.
finding binding
boundCD19 CAR-T (tisagenlecleucel, axicabtagene ciloleucel) produced complete responses in 70-90 percent of relapsed/refractory pediatric ALL and 40-60 percent of refractory DLBCL in pivotal trials; B-cell aplasia and cytokine release syndrome are the dominant toxicities. The class established CAR-T as a treatment modality for hematologic malignancies.
inspect finding →
source binding
source-boundvs_58e757f58ff80794
inspect source →
review context
unverified1 reviewable changes and 0 evaluation records target this atom or its bound objects.
Evidence statement
CD19 CAR-T (tisagenlecleucel, axicabtagene ciloleucel) produced complete responses in 70-90 percent of relapsed/refractory pediatric ALL and 40-60 percent of refractory DLBCL in pivotal trials; B-cell aplasia and cytokine release syndrome are the dominant toxicities. The class established CAR-T as a treatment modality for hematologic malignancies.
extraction method
manual_curation
support relation
unknown
condition refs
vcnd_92ac8a18979785f9
Caveats
events
vev_66e28575892e7972finding.assertedManual finding added to frontier state
agent:immuno-research-bot-2026-05-09 · 2026-05-09
reviewable changes
vpr_2496f7eb56a7dd9ffinding.addManual finding added to frontier state
applied · agent:immuno-research-bot-2026-05-09 · 2026-05-09
evaluations
No evaluation rows are attached.